164 related articles for article (PubMed ID: 27692964)
1. The Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally Critical.
Galilee M; Britan-Rosich E; Griner SL; Uysal S; Baumgärtel V; Lamb DC; Kossiakoff AA; Kotler M; Stroud RM; Marx A; Alian A
Structure; 2016 Nov; 24(11):1936-1946. PubMed ID: 27692964
[TBL] [Abstract][Full Text] [Related]
2. An unusual helix turn helix motif in the catalytic core of HIV-1 integrase binds viral DNA and LEDGF.
Merad H; Porumb H; Zargarian L; René B; Hobaika Z; Maroun RG; Mauffret O; Fermandjian S
PLoS One; 2009; 4(1):e4081. PubMed ID: 19119323
[TBL] [Abstract][Full Text] [Related]
3. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study.
Balasubramanian S; Rajagopalan M; Bojja RS; Skalka AM; Andrake MD; Ramaswamy A
J Biomol Struct Dyn; 2017 Dec; 35(16):3469-3485. PubMed ID: 27835934
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
[TBL] [Abstract][Full Text] [Related]
5. Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting.
Anisenko AN; Knyazhanskaya ES; Zalevsky AO; Agapkina JY; Sizov AI; Zatsepin TS; Gottikh MB
Sci Rep; 2017 Jul; 7(1):5649. PubMed ID: 28717247
[TBL] [Abstract][Full Text] [Related]
6. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
Zhu HM; Chen WZ; Wang CX
Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
[TBL] [Abstract][Full Text] [Related]
7. C-Terminal Domain of Integrase Binds between the Two Active Sites.
Roberts VA
J Chem Theory Comput; 2015 Sep; 11(9):4500-11. PubMed ID: 26575940
[TBL] [Abstract][Full Text] [Related]
8. An inhibitory monoclonal antibody binds at the turn of the helix-turn-helix motif in the N-terminal domain of HIV-1 integrase.
Yi J; Arthur JW; Dunbrack RL; Skalka AM
J Biol Chem; 2000 Dec; 275(49):38739-48. PubMed ID: 10969077
[TBL] [Abstract][Full Text] [Related]
9. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
[TBL] [Abstract][Full Text] [Related]
10. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex.
Heuer TS; Brown PO
Biochemistry; 1998 May; 37(19):6667-78. PubMed ID: 9578550
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.
Chen JC; Krucinski J; Miercke LJ; Finer-Moore JS; Tang AH; Leavitt AD; Stroud RM
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8233-8. PubMed ID: 10890912
[TBL] [Abstract][Full Text] [Related]
12. Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments.
Tintori C; Esposito F; Morreale F; Martini R; Tramontano E; Botta M
Bioorg Med Chem Lett; 2015 Aug; 25(15):3013-6. PubMed ID: 26048795
[TBL] [Abstract][Full Text] [Related]
13. Influence of the amino-terminal sequence on the structure and function of HIV integrase.
Eilers G; Gupta K; Allen A; Zhou J; Hwang Y; Cory MB; Bushman FD; Van Duyne G
Retrovirology; 2020 Aug; 17(1):28. PubMed ID: 32867805
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site.
Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Newman J; Martyn J; Coates JA; Ede NJ; Rea P; Deadman JJ
Chembiochem; 2011 Oct; 12(15):2311-5. PubMed ID: 21850718
[TBL] [Abstract][Full Text] [Related]
15. INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication.
Dixit U; Bhutoria S; Wu X; Qiu L; Spira M; Mathew S; Harris R; Adams LJ; Cahill S; Pathak R; Rajesh Kumar P; Nguyen M; Acharya SA; Brenowitz M; Almo SC; Zou X; Steven AC; Cowburn D; Girvin M; Kalpana GV
Nat Commun; 2021 May; 12(1):2743. PubMed ID: 33980829
[TBL] [Abstract][Full Text] [Related]
16. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
Voet AR; Maeyer MD; Debyser Z; Christ F
Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
[TBL] [Abstract][Full Text] [Related]
17. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.
Wang JY; Ling H; Yang W; Craigie R
EMBO J; 2001 Dec; 20(24):7333-43. PubMed ID: 11743009
[TBL] [Abstract][Full Text] [Related]
18. Reduced HIV-1 integrase flexibility as a mechanism for raltegravir resistance.
Dewdney TG; Wang Y; Kovari IA; Reiter SJ; Kovari LC
J Struct Biol; 2013 Nov; 184(2):245-50. PubMed ID: 23891838
[TBL] [Abstract][Full Text] [Related]
19. Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis.
Elliott JL; Eschbach JE; Koneru PC; Li W; Puray-Chavez M; Townsend D; Lawson DQ; Engelman AN; Kvaratskhelia M; Kutluay SB
Elife; 2020 Sep; 9():. PubMed ID: 32960169
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
Gupta K; Turkki V; Sherrill-Mix S; Hwang Y; Eilers G; Taylor L; McDanal C; Wang P; Temelkoff D; Nolte RT; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
PLoS Biol; 2016 Dec; 14(12):e1002584. PubMed ID: 27935939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
